Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G | 2018-06-11 | Broadfin Capital, LLC | ADMA BIOLOGICS, INC. | 3,249,829 | 7.2% | EDGAR |
SC 13D/A | 2018-05-21 | Biotest Pharmaceuticals Corp | ADMA BIOLOGICS, INC. | 10,109,534 | 27.5% | EDGAR |
SC 13G/A | 2018-02-14 | Consonance Capital Management LP | ADMA BIOLOGICS, INC. | 3,070,624 | 6.8% | EDGAR |
SC 13G/A | 2018-02-13 | Broadfin Capital, LLC | ADMA BIOLOGICS, INC. | 1,102,200 | 2.4% | EDGAR |
SC 13D/A | 2017-11-20 | Biotest AG | ADMA BIOLOGICS, INC. | 18,700,694 | 41.3% | EDGAR |
SC 13D/A | 2017-11-16 | Aisling Capital II LP | ADMA BIOLOGICS, INC. | 3,608,171 | 8.0% | EDGAR |
SC 13G/A | 2017-11-15 | PERCEPTIVE ADVISORS LLC | ADMA BIOLOGICS, INC. | 3,821,102 | 10.4% | EDGAR |
SC 13D | 2017-06-16 | Biotest AG | ADMA BIOLOGICS, INC. | 4,295,580 | 25.0% | EDGAR |
SC 13G | 2017-02-14 | PERCEPTIVE ADVISORS LLC | ADMA BIOLOGICS, INC. | 721,102 | 5.6% | EDGAR |
SC 13G/A | 2017-02-13 | Broadfin Capital, LLC | ADMA BIOLOGICS, INC. | 1,113,293 | 8.6% | EDGAR |
SC 13G/A | 2017-02-13 | Consonance Capital Management LP | ADMA BIOLOGICS, INC. | 1,151,135 | 8.9% | EDGAR |
SC 13D/A | 2017-01-30 | BIOMARK CAPITAL FUND IV LP | ADMA BIOLOGICS, INC. | 1,473,391 | 11.4% | EDGAR |
SC 13D/A | 2017-01-25 | Aisling Capital II LP | ADMA BIOLOGICS, INC. | 3,608,171 | 28.0% | EDGAR |
SC 13D/A | 2017-01-24 | Grossman Jerrold B | ADMA BIOLOGICS, INC. | 528,016 | 4.1% | EDGAR |
SC 13D/A | 2017-01-24 | Grossman Adam S | ADMA BIOLOGICS, INC. | 839,957 | 6.5% | EDGAR |
SC 13G/A | 2016-02-11 | Consonance Capital Management LP | ADMA BIOLOGICS, INC. | 957,865 | 8.9% | EDGAR |
SC 13G | 2015-03-19 | Broadfin Capital, LLC | ADMA BIOLOGICS, INC. | 964,193 | 9.2% | EDGAR |
SC 13G | 2015-02-17 | Consonance Capital Management LP | ADMA BIOLOGICS, INC. | 822,407 | 8.9% | EDGAR |
SC 13D/A | 2013-10-28 | Burrill Capital Fund IV, L.P. | ADMA BIOLOGICS, INC. | 1,433,304 | 15.5% | EDGAR |
SC 13D/A | 2013-10-23 | Aisling Capital II LP | ADMA BIOLOGICS, INC. | 3,620,143 | 39.2% | EDGAR |